01
Cash & equivalents increased 55.8%
Cash & equivalents changed +55.8% from the comparable as-filed period.
$306.7M→$477.9MComparable → current
· Pharmaceutical Preparations
RESEARCH SNAPSHOTMoonLake Immunotherapeutics's latest supported as-filed period reports net income of -$61.8M, 11.9% below the comparable as-filed period. Every value below links to its SEC accession and metric lineage.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Cash & equivalents changed +55.8% from the comparable as-filed period.
Debt changed +35.6% from the comparable as-filed period.
Net income changed -11.9% from the comparable as-filed period.
Operating income changed -1.6% from the comparable as-filed period.
Each point keeps the date investors could first observe it and its accession.
MLTX · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001821586-26-000010SEC ↗8-KAug 10, 2026Period Aug 10, 20260001213900-26-086939SEC ↗4Jul 29, 2026Period Jul 27, 20260001213900-26-082804SEC ↗4Jul 23, 2026Period Jul 21, 20260001213900-26-080869SEC ↗4Jul 21, 2026Period Jul 20, 20260001213900-26-080133SEC ↗4Jul 20, 2026Period Jul 15, 20260001213900-26-079376SEC ↗8-KJul 15, 2026Period Jul 14, 20260001213900-26-078031SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Jul 27, 2026Filed Jul 29, 2026 | Reich KristianChief Scientific Officer | Open Market SaleIndirect | 1,100 | $20 | $22,000 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Research & development changed +0.9% from the comparable as-filed period.
Stock-based compensation changed -23.1% from the comparable as-filed period.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001213900-26-077564